About Us
Home / About Us
mark@finsneuro.org (secure)
Mark M. Stecker MD, PhD, FAAN, FACNS, FASNM
30+ years of experience in Neurology/Neuroscience
After obtaining his PhD in physics, he obtained his MD through the Harvard-MIT HST program. He completed his neurology residency and fellowship at the University of Pennsylvania. He was assistant and associate professor of neurology and division chief for peri-operative neurology. On his move to Geisinger medical center, he directed the epilepsy program and intra-operative neurophysiologic monitoring. He also began a longstanding basic science laboratory studying peripheral nerve physiology. At Marshall University School of Medicine he was the director of the neurophysiology lab, assistant chair for neurology. During his time at Marshall, he also was director of the stroke program and lead the new program to Joint Commission Certification. He was also involved in the movement disorder program at Marshall and was chair of the medical school curriculum committee. His next position was as the founding chair of neuroscience at Winthrop University Hospital. This was followed by time as chief of neurology at CCFMG/UCSF Fresno. He currently is president of the Fresno Institute of Neuroscience.
Mona Stecker, DNP NP-BC, CNRN, SCRN
Dr. Stecker graduated from West Virginia University in 2011 with a Doctor of Nursing Practice Degree. She received her Master’s degree from Misericordia University in 2003 as a Nurse Practitioner, and has a Bachelor’s Degree from Wilkes University where she graduated in 1997 majoring in Nursing with a minor in Business Administration. Dr. Stecker has worked in the field of Neuroscience for over 15 years as an Advanced Practice Nurse. Dr. Stecker has served on the board of the American Association of Neuroscience Nurses from 2012 to 2015 and served as President of the Agnes Marshall Walker Foundation (fund-raising arm of AANN) from 2015 to 2018. Mona is currently president of the AANN in 2023-2034.
Dr. Stecker has published articles in peer reviewed journals on topics such as Epilepsy, Quality Improvement, and Education and Collaboration. Dr. Stecker is originally from Pennsylvania and has lived in California since 2016.
Dr. Stecker has published articles in peer reviewed journals on topics such as Epilepsy, Quality Improvement, and Education and Collaboration. Dr. Stecker is originally from Pennsylvania and has lived in California since 2016.
providers@finsneuro.org (secure) or mona@finsneuro.com (general)
Our Colleagues and Collaborators
Terry Patterson, PhD
Patterson NeuroConsulting Ltd -- Specialized in NeuoStimulator TargetingA 25 year Private practice targeted upon Movement Disorders: such as Essential Tremor,Parkinson's and Dystonia in the main. Consultation is available on every aspect of such disorders. Practiceis centered on the East Coast in DC, Maryland and Pennsylvania. But, consultation and other services are available nationwide
Jay L. Shils, Ph.D., D.ABNM, FASNM, FACNS
Jay L. Shils, Ph.D., D.ABNM, FASNM, FACNS is currently the director of intraoperative neurophysiological monitoring at Rush University Medical School and Professor in the department of Anesthesiology at Rush Medical Center. He received his Bachelor of Science degree in electrical engineering from Syracuse University, and both his masters and PhD in Bio-Engineering at The University of Pennsylvania with a thesis dissertation subject – “The bispectrum of the human electroencephalogram”. Heinvestigated interactions in the visual system and study EEG in epilepsy. Dr. Shils has been involved in intraoperative neuromonitoring since 1994 specializing in microelectrode neurophysiology for movement disorders. Dr. Shils is the co-editor of one book on intraoperative neuromonitoring and two neuromodulation related books which are his primary interests. Dr. Shils is a past president of the ASNM and the ISIN, the ASNM’s present secretary and is the founding secretary of the ISIN. Over the years Dr. Shils has presented at over 100 national and international has published on MER, DBS, neuromodulation, and intraoperative monitoring techniques.
Linda Kelly, MS, R. EEG/EP T., R. NCS.T., CNCT, FASET, CSSGB
Linda Kelly has been in the field of Neurodiagnostics for over 20 years. She graduated from the Crozer School of Clinical Neurophysiology and went on to receive her undergraduate degree from Widener University and Master’s of Science in Healthcare Administration from St. Joseph’s University. Linda has worked across the spectrum in a clinical setting as a technologist, manager, and administrative director. Her passion has always been education. Linda has worked at both hospital and college-based, accredited neurodiagnostic technology programs as an instructor, clinical coordinator, and program director. Program and curriculum development are strengths and Linda currently has the only Quality Matters (QM) certified, online neurodiagnostic course in the country.
Jan Hoffman, MHA
Ms. Hoffman received her Masters of Health Administration (MHA) degree from the University of Washington (Seattle). Following administrative fellowships at The Mason Clinic (Seattle, WA) and Bristol Bay Area Hospital (Dillingham, AK), Ms. Hoffman served as a Captain in the U.S. Air Force Medical Service Corps (MSC), assigned to Vandenberg Air Force Base (CA) and Yokota Air Base (Japan). As an administrator for the department to service line clinical and research operations, Ms. Hoffman has also been responsible for new program development, implementation and management, residency program administration, and clinical and basic science research administration for several multi-facility and university-based systems including: - Geisinger Health System (Danville, PA) – Anesthesiology Service Line (2 hospitals and 3 surgery centers), and developed / implemented system-wide Geisinger Blood Management Program- Partners Healthcare System: Massachusetts General Hospital (Boston, MA) – Cutaneous Biology Research Center (14 independent research laboratories)- Partners Healthcare System: Brigham and Women’s Hospital (Boston, MA) – Department of Emergency Medicine, Harvard Area Emergency Medicine Residency and Harvard/Brigham International Emergency Medicine Fellowship programs - Neurology Consultants of Danville, PSC (Danville, KY) - Clinical Practice Manager- MD Anderson Cancer Center (Houston, TX) – Department of Hematology, Blood and Marrow Transplantation (coordinating with Divisions of Leukemia, Lymphoma, and Molecular Hematology)- University of California San Francisco –Departments of General Internal Medicine and Pediatrics, San Francisco General Hospital, and (interim grant manager) The Northern California Comprehensive Sickle Cell Center (multi-facility clinical and research operation) - State University of New York – Department of Psychiatry, University Hospital (Stony Brook, NY) and Veteran’s Administration Medical Center Department of Psychiatry (Northport, NY)
Maureen Carroll, BS, R. EEG/EP T., RPSGT, CNIM, FASET
Maureen Carroll is currently ASET-The Neurodiagnostic Society’s Online Learning and Development Manager. She graduated Magna Cum Laude from Widener University with a BS degree in Allied Health and a minor in Instructional Methods and Technology. Maureen is an experienced technologist who graduated from a CAAHEP accredited program and holds registry credentials in EEG, Evoked Potentials, Polysomnography and Intraoperative Neurophysiological monitoring. She also has the distinction of ASET Fellow (FASET). Ms. Carroll is an experienced and passionate educator, past instructor, program director and Neurodiagnostic lab manager. She was the 2006 Recipient of the Theda Sannit Outstanding Educator Award and served 9 years on the Committee on Accreditation in Neurodiagnostic Technology (CoA-NDT).
.jpeg)
Dr. Michael Marmor, PhD
Dr. Marmor has a PhD in experimental nuclear physics from the State University of New York at Stony Brook. Following completion of his PhD, he worked as a program officer at the Rockefeller Foundation in environmental health sciences. He then transitioned to a career in epidemiology, biostatistics and environmental health through postdoctoral work at the New York University Institute of Environmental and coursework at the Columbia University School of Public Health. Dr. Marmor is Research Professor, NYU Grossman School of Medicine, with a primary appointment in the Departments of Population Health, Division of Epidemiology; and secondary appointments in Environmental Medicine; and Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine. He has been principal investigator on more than $22 million (direct costs) of research projects and has served as co-investigator on many projects. He has investigated the neurological sequelae of exposure to contaminants from the World Trade Center terrorist attacks of 2001, and the effects of lead and Toxocara canis infection on the neuropsychological development of children. He has directed research sites for U.S. Food and Drug Administration-supervised phase I, II, IIa and III clinical trials of preventive vaccines, medical devices, and diagnostic tests. He has designed, directed and analyzed studies of risk factors for and consequences of HIV, HPV, tuberculosis, ocular conditions, cardiovascular diseases, asthma, and occupational exposures. He is skilled in a range of biostatistical techniques, including categorical analyses, logistic regression, Cox regression and generalized linear models. He is expert in the use of cohort and case-control methods for the study of disease acquisition, transmission or progression; risks of different outcomes given environmental exposure; design of studies; development of sample size requirements; writing of clinical protocols; analysis of sample size requirements; design of questionnaires and case report forms; and creation of manuals of procedures. He has published over 140 peer-reviewed manuscripts, written successful grant proposals and handled applications to institutional review boards (IRBs). He has interacted with data safety and monitoring boards. He has created and interacted with community advisory boards. He has taught epidemiologic and clinical trial methods to doctoral and medical students and has supervised PhD theses. He is skilled at conveying complex information to members of the general public. Dr. Marmor can assist with the development of studies to be implemented in a single medical practice, in a single medical center, or in multi-institutional networks.
.jpg)
Steve Rauchman, M.D.
Ophthalmologist and ophthalmic surgeon with extensive experience in comprehensive medical and surgical practice. Principal investigator in nationwide pharmaceutical clinical trials, communicating with large pharmaceutical companies on both research and business levels. Cultivates personal and business relationships with Clinical Research Organizations (CROs), a conduit for FDA authorized pharmaceutical trials. Possesses detailed understanding and ensures strict adherence to government regulatory requirements. Assembles and manages a team of clinical staff to execute trials on drugs in development. Establishes and maintains a medical/legal partnership with large law firms, testifies in trials, and is a recognized expert in the ophthalmologic manifestations of Traumatic Brain Injuries (TBI). Reviews articles before publication for a peer-reviewed neuroscience journal.
Allison B. Reiss, M.D.
Allison B. Reiss, M.D. is an internal medicine physician, educator, and molecular biologist with more than 25 years of experience in bench-to-bedside research studying the immune system and its effects on the brain and heart. She is a graduate of SUNY Downstate College of Medicine and is currently an Associate Professor of Medicine at the NYU Long Island School of Medicine where she teaches basic science and is Course Director of a medical student elective on basic and translational research. She is Head of the Inflammation Laboratory at NYU Langone Hospital-Long Island.
As an American Board of Internal Medicine–certified physician, her clinical experiences have given her the tools to integrate laboratory and patient-based studies into a comprehensive whole aimed at finding innovative treatments for Alzheimer’s disease and other neurodegenerative disorders, which affect so many people and their families.
In an effort to inspire new generations of clinician–scientists to confront the medical challenges presented by the growing number of persons with cognitive dysfunction, she is deeply involved in educating professionals and the community on the issues surrounding the pathogenesis and treatment of cognitive dysfunction. It is her ardent belief that we have a responsibility to improve medical care, expand medical education, and discover innovative treatments for our patients. To these ends, she has lectured at national meetings on many topics, including Alzheimer’s disease and Covid-19, particularly the impact of Covid-19 on our vulnerable older population.
Dr. Reiss has received recognition for her work from the Alzheimer’s Foundation of America, the American Heart Association, the National Institutes of Health and the Alzheimer’s Disease Resource Center.
She has authored numerous papers in peer-reviewed journals on Alzheimer’s disease, cholesterol metabolism and most recently, Covid-19 and its complications. She serves as an associate editor for Frontiers in Aging Neuroscience, is an editorial board member of the Journal of Investigative Medicine, and is Neurology section Editor-in-Chief of the journal Medicina. To learn more about Allison and her research see the website https://reisslab.wordpress.com/
As an American Board of Internal Medicine–certified physician, her clinical experiences have given her the tools to integrate laboratory and patient-based studies into a comprehensive whole aimed at finding innovative treatments for Alzheimer’s disease and other neurodegenerative disorders, which affect so many people and their families.
In an effort to inspire new generations of clinician–scientists to confront the medical challenges presented by the growing number of persons with cognitive dysfunction, she is deeply involved in educating professionals and the community on the issues surrounding the pathogenesis and treatment of cognitive dysfunction. It is her ardent belief that we have a responsibility to improve medical care, expand medical education, and discover innovative treatments for our patients. To these ends, she has lectured at national meetings on many topics, including Alzheimer’s disease and Covid-19, particularly the impact of Covid-19 on our vulnerable older population.
Dr. Reiss has received recognition for her work from the Alzheimer’s Foundation of America, the American Heart Association, the National Institutes of Health and the Alzheimer’s Disease Resource Center.
She has authored numerous papers in peer-reviewed journals on Alzheimer’s disease, cholesterol metabolism and most recently, Covid-19 and its complications. She serves as an associate editor for Frontiers in Aging Neuroscience, is an editorial board member of the Journal of Investigative Medicine, and is Neurology section Editor-in-Chief of the journal Medicina. To learn more about Allison and her research see the website https://reisslab.wordpress.com/
